Serum levels of leptin and proinflammatory cytokinesin advanced stage non-small cell lung cancer.

被引：0
|
作者：
Topuz, E
Tas, F
Argon, A
Yildiz, DD
Oguz, H
Yasasever, V
Eralp, Y
Aydiner, A
机构：
[1] Univ Istanbul, Istanbul, Turkey
[2] Sisli Etfal Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：189S / 189S
页数：1
相关论文
共 50 条
  • [31] Pathologic classification as a predictive factor in advanced non-small cell lung cancer.
    Richardet, E.
    Richardet, M.
    Perelli, L.
    Magri, I.
    Castagneris, N.
    Cortes, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Access to biomarker testing in patients with advanced non-small cell lung cancer.
    Borghaei, Hossein
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh S.
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Ganti, Apar Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
    Jin, Ying
    Zhao, Li
    Peng, Fang
    CLINICS, 2013, 68 (05) : 686 - 693
  • [34] Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)
    Görn, M
    Anige, M
    Burkholder, I
    Müller, B
    Scheffler, A
    Edler, L
    Boeters, I
    Panse, J
    Schuch, G
    Hossfeld, DK
    Laack, E
    LUNG CANCER, 2005, 49 (01) : 71 - 76
  • [35] Association Between Serum Adipokines Levels and Quality of Life in Advanced Non-small Cell Lung Cancer
    Demiray, G.
    Yaren, A.
    Ozkan, S.
    Degirmencioglu, S.
    Taskoylu, B. Y.
    Dogu, G. G.
    Rota, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S122 - S122
  • [36] The prognostic and predictive significance of serum thiols and disulfide levels in advanced non-small cell lung cancer
    Karatas, Fatih
    Acat, Murat
    Sahin, Suleyman
    Inci, Fatih
    Karatas, Gulsah
    Neselioglu, Salim
    Haskul, Ismail
    Erel, Ozcan
    AGING MALE, 2020, 23 (05): : 619 - 628
  • [37] Serum antioxidant levels and survival time in advanced non-small cell lung cancer patients.
    Wirasorn, Kosin
    Hongprabhas, Pranithi
    Pisprasert, Veeradej
    Klarod, Kulthida
    Boonsiri, Patcharee
    CANCER RESEARCH, 2013, 73 (08)
  • [38] Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer
    De Vita, F
    Orditura, M
    Auriemma, A
    Infusino, S
    Roscigno, A
    Catalano, G
    ONCOLOGY REPORTS, 1998, 5 (03) : 649 - 652
  • [39] Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small cell lung cancer.
    Wang, Qi
    Li, Xuefei
    Ren, Shengxiang
    Cheng, Ningning
    Cai, Weijing
    Zhao, Chao
    Zhao, Mingchuan
    Li, Jiayu
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Serum vascular endothelial growth factor (VEGF) and Bcl-2 levels in advanced stage non-small cell lung cancer
    Tas, Faruk
    Duranyildiz, Derya
    Oguz, Hilal
    Camlica, Hakan
    Yasasever, Vildan
    Topuz, Erkan
    CANCER INVESTIGATION, 2006, 24 (06) : 576 - 580
12345